What is Mobix Labs' operating income?

Mobix Labs' total operating income in 2025 was -$37.69 million, based on the following breakdown: Total Gross Profit: $5.01 million Total Operating Expenses: $42.70 million

Mobix Labs (MOBX) Financials

$1.98 +0.06 (+2.86%)

As of 02:25 PM Eastern

Compare

Annual Income Statements for Mobix Labs

This table shows Mobix Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	9/30/2023	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-0.78	-40	-21	-46
Consolidated Net Income / (Loss)	-0.78	-40	-20	-46
Net Income / (Loss) Continuing Operations	-0.78	-40	-20	-46
Total Pre-Tax Income	-0.78	-40	-22	-46
Total Operating Income	-1.26	-36	-46	-38
Total Gross Profit	0.00	-0.40	2.55	5.01
Total Revenue	0.00	1.22	6.44	9.91
Operating Revenue	-	1.22	6.44	9.91
Total Cost of Revenue	0.00	1.62	3.89	4.91
Operating Cost of Revenue	-	1.62	3.89	4.91
Total Operating Expenses	1.26	35	49	43
Selling, General & Admin Expense	1.26	24	42	40
Research & Development Expense	-	11	5.78	2.42
Impairment Charge	-	0.00	1.33	0.73
Total Other Income / (Expense), net	0.48	-4.01	24	-8.43
Interest Expense	-	3.36	1.58	2.33
Other Income / (Expense), net	0.27	-0.66	26	-6.11
Income Tax Expense	0.00	0.07	-2.43	0.01
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	0.66	0.00
Basic Earnings per Share	($0.26)	($2.71)	($0.73)	($1.01)
Weighted Average Basic Shares Outstanding	6.80M	14.61M	28.42M	45.47M
Diluted Earnings per Share	($0.26)	($2.71)	($0.75)	($1.01)
Weighted Average Diluted Shares Outstanding	4.80M	14.61M	29.48M	45.47M
Weighted Average Basic & Diluted Shares Outstanding	2.86M	-	35.81M	66.31M

This table shows Mobix Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-7.09	0.94	-2.41	-7.68	-12	-20	-2.29	-8.27	-16	-10	-5.85
Consolidated Net Income / (Loss)	-7.09	0.94	-1.75	-7.68	-12	-20	-2.29	-8.27	-16	-10	-5.85
Net Income / (Loss) Continuing Operations	-7.14	0.94	-1.75	-7.68	-12	-20	-2.29	-8.27	-16	-10	-5.85
Total Pre-Tax Income	-7.09	-0.35	-1.77	-9.18	-11	-20	-2.30	-8.27	-16	-10	-5.85
Total Operating Income	-4.74	-17	-8.56	-9.35	-11	-15	-7.83	-8.07	-7.17	-8.83	-6.09
Total Gross Profit	0.00	-0.04	0.19	0.73	1.67	1.69	1.02	1.35	0.95	0.58	0.18
Total Revenue	0.43	0.29	1.15	2.06	2.95	3.17	2.51	2.35	1.88	1.88	0.97
Operating Revenue	0.43	0.29	1.15	2.06	2.95	3.17	2.51	2.35	1.88	1.88	0.97
Total Cost of Revenue	0.43	0.33	0.95	1.33	1.28	1.48	1.49	1.00	0.93	1.29	0.79
Operating Cost of Revenue	0.43	0.33	0.95	1.33	1.28	1.48	1.49	1.00	0.93	1.29	0.79
Total Operating Expenses	4.69	17	8.76	10	13	16	8.85	9.42	8.12	9.41	6.28
Selling, General & Admin Expense	2.91	16	7.36	8.71	10	16	8.13	8.21	7.51	8.97	5.85
Research & Development Expense	1.84	1.56	1.40	1.37	1.45	0.61	0.72	0.49	0.60	0.44	0.43
Total Other Income / (Expense), net	-2.35	17	6.79	0.16	0.05	-5.21	5.53	-0.20	-8.55	-1.32	0.24
Interest Expense	2.17	0.86	0.25	0.13	0.35	0.21	0.27	0.55	1.29	1.38	1.39
Other Income / (Expense), net	-0.18	18	7.04	0.29	0.40	-5.00	5.81	0.34	-7.26	0.06	1.63
Income Tax Expense	0.05	-1.28	-0.02	-1.51	0.37	-0.00	-0.01	-0.00	0.02	-0.02	0.00
Basic Earnings per Share	($0.36)	$0.04	($0.09)	($0.25)	($0.43)	($0.52)	($0.57)	($0.17)	($0.26)	($0.16)	($0.59)
Weighted Average Basic Shares Outstanding	14.61M	18.62M	28.05M	30.55M	28.42M	38.43M	4.02M	48.79M	45.47M	63.06M	9.84M
Diluted Earnings per Share	($0.36)	$0.04	($0.21)	($0.25)	($0.33)	($0.52)	($0.57)	($0.17)	($0.26)	($0.16)	($0.59)
Weighted Average Diluted Shares Outstanding	14.61M	23.32M	29.20M	30.55M	29.48M	38.43M	4.02M	48.79M	45.47M	63.06M	9.84M
Weighted Average Basic & Diluted Shares Outstanding	0.00	25.81M	27.19M	30.59M	35.81M	36.99M	53.31M	54.73M	66.31M	103.08M	13.44M

This table details how cash moves in and out of Mobix Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	9/30/2023	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	-0.06	-0.09	0.18	3.01
Net Cash From Operating Activities	-0.32	-15	-18	-10
Net Cash From Continuing Operating Activities	-0.32	-15	-18	-10
Net Income / (Loss) Continuing Operations	-0.78	-40	-20	-46
Consolidated Net Income / (Loss)	-0.78	-40	-20	-46
Depreciation Expense	-	0.45	0.47	0.37
Amortization Expense	-	0.84	1.54	1.69
Non-Cash Adjustments To Reconcile Net Income	-0.27	19	29	33
Changes in Operating Assets and Liabilities, net	0.72	4.71	-29	0.93
Net Cash From Investing Activities	70	-0.63	-1.11	0.00
Net Cash From Continuing Investing Activities	70	-0.63	-1.11	0.00
Purchase of Property, Plant & Equipment	-	0.00	-0.04	-0.03
Acquisitions	-	-0.63	-1.06	0.00
Sale of Property, Plant & Equipment	-	-	0.00	0.03
Net Cash From Financing Activities	-70	15	20	13
Net Cash From Continuing Financing Activities	-70	15	20	13
Repayment of Debt	0.00	-1.46	-3.21	-1.79
Repurchase of Common Equity	-71	-0.93	-6.95	0.00
Issuance of Debt	0.66	3.14	1.65	5.32
Issuance of Common Equity	0.00	14	7.11	5.25
Other Financing Activities, net	0.00	0.91	21	4.35
Cash Interest Paid	-	0.06	0.52	1.81
Cash Income Taxes Paid	-	0.00	0.00	0.00

This table details how cash moves in and out of Mobix Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-0.03	15	-12	-2.79	0.06	0.14	-13	-0.54	3.03	-3.01	-5.19
Net Cash From Operating Activities	-1.56	-3.60	-8.09	-3.08	-3.62	-0.93	-0.59	-4.08	-4.51	-4.77	-4.25
Net Cash From Continuing Operating Activities	-1.56	-3.60	-8.09	-3.08	-3.62	-0.93	-14	-4.08	-4.51	-4.77	-12
Net Income / (Loss) Continuing Operations	-7.09	0.94	-1.75	-7.68	-12	-20	-2.29	-8.27	-16	-10	-5.85
Consolidated Net Income / (Loss)	-7.09	0.94	-1.75	-7.68	-12	-20	-2.29	-8.27	-16	-10	-5.85
Depreciation Expense	0.11	0.11	0.12	0.13	0.12	0.12	0.12	0.06	0.06	0.05	0.03
Amortization Expense	0.21	0.24	0.40	0.48	0.43	0.47	0.41	0.41	0.41	0.41	0.40
Non-Cash Adjustments To Reconcile Net Income	3.24	-4.37	-7.01	3.36	37	15	-15	7.32	13	6.53	-5.85
Changes in Operating Assets and Liabilities, net	1.96	-0.51	0.15	0.63	-30	3.38	2.91	-3.60	-2.04	-1.62	-0.46
Net Cash From Financing Activities	1.56	18	-2.68	0.25	3.68	1.07	0.98	3.52	7.56	1.76	6.55
Net Cash From Continuing Financing Activities	1.56	18	-2.68	0.25	3.68	1.07	0.98	3.52	7.56	1.76	6.55
Repayment of Debt	-0.64	-0.36	-1.85	-0.40	-0.60	-0.03	-0.09	-0.98	-0.69	-1.27	-1.83
Issuance of Debt	0.84	0.45	-	0.53	0.68	0.68	1.05	0.85	2.74	1.72	3.02
Issuance of Common Equity	2.04	3.29	-	0.05	3.78	0.60	-	3.65	1.00	1.25	5.36
Cash Interest Paid	0.06	0.08	0.29	0.09	0.07	0.06	0.19	0.50	1.06	1.18	0.18

This table presents Mobix Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	81	10	19	39	37
Total Current Assets	0.67	0.18	0.83	5.27	6.72
Cash & Equivalents	0.24	0.18	0.09	0.27	3.27
Accounts Receivable	-	-	0.05	2.81	1.41
Inventories, net	-	-	0.32	1.73	1.44
Prepaid Expenses	0.43	0.00	0.37	0.47	0.59
Plant, Property, & Equipment, net	0.00	0.00	1.86	1.18	0.33
Total Noncurrent Assets	80	9.84	16	33	30
Goodwill	-	-	5.22	16	16
Intangible Assets	-	-	5.29	15	14
Other Noncurrent Operating Assets	80	9.84	5.56	1.36	0.49
Total Liabilities & Shareholders' Equity	81	10	19	39	37
Total Liabilities	1.74	2.42	22	34	37
Total Current Liabilities	0.07	1.02	20	26	28
Short-Term Debt	-	0.66	5.08	2.14	5.09
Accounts Payable	-	-	9.00	11	8.98
Accrued Expenses	0.07	0.36	4.52	10	11
Current Deferred Revenue	-	-	0.00	2.38	2.32
Other Current Liabilities	0.00	-	1.83	0.43	0.27
Total Noncurrent Liabilities	1.67	1.40	1.37	7.45	9.66
Long-Term Debt	-	-	0.00	1.28	1.10
Capital Lease Obligations	-	-	-	-	0.10
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	0.09	0.32	0.32
Other Noncurrent Operating Liabilities	1.67	1.40	1.28	5.85	8.15
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-1.06	-2.15	-5.34	5.53	-0.34
Total Preferred & Common Equity	-1.06	-2.15	-5.34	5.53	-0.34
Total Common Equity	-1.06	-2.15	-5.34	5.53	-0.34
Common Stock	0.00	0.00	78	110	150
Retained Earnings	-1.06	-2.15	-84	-104	-151

This table presents Mobix Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025	12/31/2025	3/31/2026
Total Assets	19	41	29	41	37	37	35	33	35
Total Current Assets	0.83	16	4.45	4.07	3.82	3.97	3.68	2.87	5.49
Cash & Equivalents	0.09	15	2.99	0.21	0.41	0.78	0.24	0.27	2.56
Accounts Receivable	0.05	0.30	0.46	1.48	1.88	1.68	1.48	1.02	0.72
Inventories, net	0.32	0.42	0.36	1.91	1.24	1.11	1.25	1.17	1.29
Prepaid Expenses	0.37	0.35	0.63	0.48	0.30	0.40	0.71	0.42	0.91
Plant, Property, & Equipment, net	1.86	1.86	1.76	1.92	1.07	0.53	0.39	0.28	0.25
Total Noncurrent Assets	16	24	23	35	32	32	30	30	29
Goodwill	5.22	11	11	15	16	16	16	16	16
Intangible Assets	5.29	12	11	19	15	14	14	13	13
Other Noncurrent Operating Assets	5.56	1.42	1.38	1.52	1.57	1.64	0.50	0.39	0.33
Total Liabilities & Shareholders' Equity	19	41	29	41	37	37	35	33	35
Total Liabilities	22	37	25	33	40	36	34	28	26
Total Current Liabilities	20	21	18	26	28	31	27	25	24
Short-Term Debt	5.08	4.95	3.16	3.22	2.75	4.05	2.98	4.35	5.43
Accounts Payable	9.00	6.00	6.69	11	11	12	11	7.94	6.23
Accrued Expenses	4.52	8.55	7.04	8.84	12	12	10	10	9.83
Current Deferred Revenue	0.00	1.62	0.80	2.47	2.27	2.31	2.32	2.32	2.32
Other Current Liabilities	0.32	0.33	0.33	0.41	0.58	0.64	0.62	0.24	0.21
Total Noncurrent Liabilities	2.88	16	7.32	7.24	12	4.71	7.43	2.82	1.98
Long-Term Debt	-	-	-	-	0.87	0.55	1.38	1.92	1.01
Capital Lease Obligations	1.28	1.20	1.11	1.14	0.90	0.85	0.70	0.04	0.01
Noncurrent Deferred & Payable Income Tax Liabilities	0.09	0.19	0.18	0.36	0.32	0.31	0.31	0.29	0.29
Other Noncurrent Operating Liabilities	1.51	14	6.03	5.74	9.78	3.00	5.05	0.56	0.67
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-5.34	4.37	4.15	8.54	-3.04	0.34	0.43	4.67	8.85
Total Preferred & Common Equity	-5.34	4.37	4.15	8.54	-3.04	0.34	0.43	4.67	8.85
Total Common Equity	-5.34	4.37	4.15	8.54	-3.04	0.34	0.43	4.67	8.85
Common Stock	78	87	89	101	121	127	135	165	175
Retained Earnings	-84	-83	-85	-93	-124	-127	-135	-161	-167

This table displays calculated financial ratios and metrics derived from Mobix Labs' official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	9/30/2023	9/30/2024	9/30/2025
DEI Shares Outstanding	2,953,033.00	2,778,912.00	25,808,121.00	54,734,338.00
DEI Adjusted Shares Outstanding	2,953,033.00	2,778,912.00	25,808,121.00	54,734,338.00
DEI Earnings Per Adjusted Shares Outstanding	-0.26	-14.26	-0.80	-0.84
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	0.00%	426.31%	53.87%
EBITDA Growth	0.00%	-3,414.31%	45.96%	-121.25%
EBIT Growth	0.00%	-3,544.17%	42.32%	-109.76%
NOPAT Growth	0.00%	-2,720.81%	-30.53%	18.76%
Net Income Growth	0.00%	-5,004.95%	49.44%	-130.26%
EPS Growth	0.00%	-942.31%	72.32%	-34.67%
Operating Cash Flow Growth	0.00%	-4,456.27%	-25.72%	45.00%
Free Cash Flow Firm Growth	0.00%	0.00%	-109.11%	48.30%
Invested Capital Growth	0.00%	-75.87%	345.72%	-70.35%
Revenue Q/Q Growth	0.00%	54.74%	64.29%	-9.76%
EBITDA Q/Q Growth	0.00%	-6.75%	-43.07%	-9.67%
EBIT Q/Q Growth	0.00%	-10.69%	-39.36%	-8.97%
NOPAT Q/Q Growth	0.00%	-14.81%	-16.22%	9.70%
Net Income Q/Q Growth	0.00%	-16.92%	-28.57%	-10.00%
EPS Q/Q Growth	0.00%	0.73%	3.85%	6.48%
Operating Cash Flow Q/Q Growth	0.00%	-12.86%	-12.62%	-9.67%
Free Cash Flow Firm Q/Q Growth	0.00%	-19.63%	-4.85%	6.90%
Invested Capital Q/Q Growth	-12.44%	-39.64%	-31.53%	-50.89%
Profitability Metrics	-	-	-	-
Gross Margin	0.00%	-32.35%	39.62%	50.51%
EBITDA Margin	0.00%	-2,852.04%	-292.86%	-421.12%
Operating Margin	0.00%	-2,903.92%	-720.20%	-380.28%
EBIT Margin	0.00%	-2,957.43%	-324.14%	-441.88%
Profit (Net Income) Margin	0.00%	-3,237.01%	-310.99%	-465.41%
Tax Burden Percent	100.00%	100.17%	89.19%	100.02%
Interest Burden Percent	78.13%	109.27%	107.58%	105.31%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-496.34%	-610.69%	-468.53%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-1,034.68%	-305.24%	-1,119.24%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-1,245.47%	-999.11%	-1,307.79%
Return on Equity (ROE)	-1.79%	-1,741.81%	-1,609.80%	-1,776.32%
Cash Return on Invested Capital (CROIC)	0.00%	-374.11%	-737.39%	-360.01%
Operating Return on Assets (OROA)	0.00%	-251.74%	-72.21%	-114.96%
Return on Assets (ROA)	0.00%	-275.54%	-69.28%	-121.08%
Return on Common Equity (ROCE)	0.07%	2,866.14%	-122.24%	-1,776.32%
Return on Equity Simple (ROE_SIMPLE)	36.18%	741.83%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.88	-25	-32	-26
NOPAT Margin	0.00%	-2,032.75%	-504.14%	-266.19%
Net Nonoperating Expense Percent (NNEP)	-21.78%	538.34%	-305.45%	650.71%
Return On Investment Capital (ROIC_SIMPLE)	-	9,496.49%	-362.74%	-451.10%
Cost of Revenue to Revenue	0.00%	132.35%	60.39%	49.49%
SG&A Expenses to Revenue	0.00%	1,969.28%	649.41%	399.07%
R&D to Revenue	0.00%	902.29%	89.71%	24.40%
Operating Expenses to Revenue	0.00%	2,871.57%	759.81%	430.79%
Earnings before Interest and Taxes (EBIT)	-0.99	-36	-21	-44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.99	-35	-19	-42
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	5.65	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	81.70	4.85	3.70
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	13.65	55.05	3.96	15.36
Enterprise Value to Revenue (EV/Rev)	0.00	87.66	5.34	3.99
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.09	-1.67	0.62	-18.41
Long-Term Debt to Equity	0.00	0.00	0.23	-3.27
Financial Leverage	0.06	1.20	3.27	1.17
Leverage Ratio	1.05	6.32	23.24	14.67
Compound Leverage Factor	0.82	6.91	25.00	15.45
Debt to Total Capital	8.02%	249.21%	38.23%	105.74%
Short-Term Debt to Total Capital	8.02%	249.21%	23.91%	86.96%
Long-Term Debt to Total Capital	0.00%	0.00%	14.32%	18.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	117.97%	112.86%	0.00%	0.00%
Common Equity to Total Capital	-25.99%	-262.07%	61.77%	-5.74%
Debt to EBITDA	-0.67	-0.15	-0.18	-0.15
Net Debt to EBITDA	-0.49	-0.14	-0.17	-0.07
Long-Term Debt to EBITDA	0.00	0.00	-0.07	-0.03
Debt to NOPAT	-0.75	-0.20	-0.11	-0.23
Net Debt to NOPAT	-0.55	-0.20	-0.10	-0.11
Long-Term Debt to NOPAT	0.00	0.00	-0.04	-0.04
Altman Z-Score	24.06	-11.06	-5.42	-9.40
Noncontrolling Interest Sharing Ratio	103.70%	264.55%	92.41%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.17	0.04	0.20	0.24
Quick Ratio	0.17	0.01	0.12	0.17
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-19	-39	-20
Operating Cash Flow to CapEx	0.00%	0.00%	-41,790.91%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	-5.59	-24.79	-8.72
Operating Cash Flow to Interest Expense	0.00	-4.36	-11.62	-4.35
Operating Cash Flow Less CapEx to Interest Expense	0.00	-4.36	-11.65	-4.35
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.09	0.22	0.26
Accounts Receivable Turnover	0.00	0.00	4.50	4.69
Inventory Turnover	0.00	0.00	3.81	3.10
Fixed Asset Turnover	0.00	0.00	4.24	13.17
Accounts Payable Turnover	0.00	0.00	0.39	0.50
Days Sales Outstanding (DSO)	0.00	0.00	81.19	77.83
Days Inventory Outstanding (DIO)	0.00	0.00	95.89	117.57
Days Payable Outstanding (DPO)	0.00	0.00	930.23	737.22
Cash Conversion Cycle (CCC)	0.00	0.00	-753.15	-541.82
Capital & Investment Metrics	-	-	-	-
Invested Capital	8.08	1.95	8.69	2.58
Invested Capital Turnover	0.00	0.24	1.21	1.76
Increase / (Decrease) in Invested Capital	0.00	-6.13	6.74	-6.11
Enterprise Value (EV)	110	107	34	40
Market Capitalization	100	100	31	37
Book Value per Share	($0.73)	($1.92)	$0.19	($0.01)
Tangible Book Value per Share	($0.73)	($5.70)	($0.91)	($0.55)
Total Capital	8.25	2.04	8.95	5.85
Total Debt	0.66	5.08	3.42	6.19
Total Long-Term Debt	0.00	0.00	1.28	1.10
Net Debt	0.49	4.99	3.16	2.91
Capital Expenditures (CapEx)	0.00	0.00	0.04	-0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.36	-15	-19	-19
Debt-free Net Working Capital (DFNWC)	-0.18	-15	-19	-16
Net Working Capital (NWC)	-0.84	-20	-21	-21
Net Nonoperating Expense (NNE)	-0.11	15	-12	20
Net Nonoperating Obligations (NNO)	0.49	4.99	3.16	2.91
Total Depreciation and Amortization (D&A)	0.00	1.29	2.02	2.06
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-1,193.06%	-294.33%	-194.29%
Debt-free Net Working Capital to Revenue	0.00%	-1,185.78%	-290.20%	-161.27%
Net Working Capital to Revenue	0.00%	-1,600.74%	-323.44%	-212.58%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($0.26)	$0.00	($0.73)	($1.01)
Adjusted Weighted Average Basic Shares Outstanding	6.80M	0.00	28.42M	45.47M
Adjusted Diluted Earnings per Share	($0.26)	$0.00	($0.75)	($1.01)
Adjusted Weighted Average Diluted Shares Outstanding	4.80M	0.00	29.48M	45.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.86M	0.00	35.81M	66.31M
Normalized Net Operating Profit after Tax (NOPAT)	-0.88	-25	-32	-26
Normalized NOPAT Margin	0.00%	-2,032.75%	-489.65%	-261.07%
Pre Tax Income Margin	0.00%	-3,231.54%	-348.70%	-465.33%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	-10.79	-13.20	-18.84
NOPAT to Interest Expense	0.00	-7.42	-20.53	-11.35
EBIT Less CapEx to Interest Expense	0.00	-10.79	-13.23	-18.84
NOPAT Less CapEx to Interest Expense	0.00	-7.42	-20.56	-11.35
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-9,092.98%	-2.35%	-34.67%	0.00%

This table displays calculated financial ratios and metrics derived from Mobix Labs' official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	2,778,912.00	2,778,912.00	25,808,121.00	25,808,121.00	25,808,121.00	35,810,950.00	36,993,099.00	53,309,749.00	54,734,338.00	-	103,077,127.00
DEI Adjusted Shares Outstanding	2,778,912.00	2,778,912.00	25,808,121.00	25,808,121.00	25,808,121.00	35,810,950.00	3,699,310.00	53,309,749.00	54,734,338.00	-	10,307,713.00
DEI Earnings Per Adjusted Shares Outstanding	-2.55	0.34	-0.09	-0.30	-0.45	-0.55	-0.62	-0.16	-0.29	-	-0.57
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-58.03%	3,478.13%	2,472.50%	582.22%	1,011.93%	119.30%	14.19%	-36.29%	-40.83%	-61.37%
EBITDA Growth	-223.51%	109.68%	91.64%	9.99%	-123.59%	-2,308.35%	-48.46%	14.07%	-35.81%	56.32%	-170.58%
EBIT Growth	-246.18%	105.55%	87.68%	6.72%	-119.95%	-3,933.98%	-32.94%	14.68%	-33.33%	55.33%	-120.62%
NOPAT Growth	-2,941.95%	-87.18%	27.68%	4.01%	-136.62%	15.28%	8.57%	13.67%	36.12%	39.62%	22.19%
Net Income Growth	-423.96%	109.96%	86.66%	23.24%	-62.84%	-2,221.82%	-30.69%	-7.72%	-36.34%	48.96%	-155.48%
EPS Growth	5.26%	105.26%	77.66%	61.54%	8.33%	-1,400.00%	-30.69%	32.00%	21.21%	69.23%	-155.48%
Operating Cash Flow Growth	-1,556.07%	34.28%	-149.94%	29.34%	-132.12%	74.14%	92.76%	-32.68%	-24.63%	-412.37%	-625.60%
Free Cash Flow Firm Growth	0.00%	-100.47%	-106.77%	-1,847.01%	-619.26%	-2,208.93%	-16.33%	111.21%	107.51%	-1.38%	-137.00%
Invested Capital Growth	-75.87%	-160.05%	-23.25%	292.94%	345.72%	125.13%	-7.77%	-58.66%	-70.35%	895.07%	154.15%
Revenue Q/Q Growth	441.25%	-34.18%	301.75%	79.74%	43.54%	7.28%	-20.76%	-6.41%	-19.91%	-0.37%	-48.27%
EBITDA Q/Q Growth	51.05%	118.76%	-216.59%	-740.70%	-21.60%	-85.28%	92.16%	-386.60%	-92.19%	40.41%	51.44%
EBIT Q/Q Growth	49.36%	110.41%	-397.07%	-495.46%	-19.41%	-81.51%	89.70%	-282.15%	-86.62%	39.19%	49.13%
NOPAT Q/Q Growth	51.33%	-264.32%	50.42%	-9.18%	-19.98%	-30.44%	46.49%	-3.09%	11.21%	-23.28%	31.04%
Net Income Q/Q Growth	29.18%	113.20%	-287.49%	-338.05%	-50.24%	-71.96%	88.45%	-261.07%	-90.15%	35.63%	42.19%
EPS Q/Q Growth	44.62%	111.11%	-625.00%	-19.05%	-32.00%	-57.58%	88.45%	-183.33%	-52.94%	38.46%	42.19%
Operating Cash Flow Q/Q Growth	64.19%	-130.51%	-125.06%	61.97%	-17.64%	74.32%	36.99%	-596.93%	-10.50%	-5.58%	10.77%
Free Cash Flow Firm Q/Q Growth	441.84%	-124.05%	-543.53%	-268.08%	8.83%	-6.92%	67.58%	135.47%	-38.94%	-1,543.55%	24.20%
Invested Capital Q/Q Growth	-39.64%	-319.70%	226.86%	133.58%	-31.53%	-87.61%	365.61%	4.69%	-50.89%	315.64%	18.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.23%	-15.44%	16.86%	35.52%	56.60%	53.23%	40.62%	57.40%	50.53%	30.99%	18.97%
EBITDA Margin	-1,061.20%	302.46%	-87.77%	-410.54%	-347.80%	-600.69%	-59.42%	-308.94%	-741.39%	-443.41%	-416.19%
Operating Margin	-1,094.69%	-6,059.30%	-747.77%	-454.23%	-379.69%	-461.66%	-311.75%	-343.40%	-380.71%	-471.09%	-627.94%
EBIT Margin	-1,135.57%	179.65%	-132.84%	-440.09%	-366.11%	-619.44%	-80.53%	-328.81%	-766.21%	-467.68%	-459.90%
Profit (Net Income) Margin	-1,636.26%	328.07%	-153.10%	-373.13%	-390.56%	-626.03%	-91.24%	-352.00%	-835.76%	-540.00%	-603.40%
Tax Burden Percent	99.99%	-271.01%	99.10%	83.61%	103.33%	99.99%	99.78%	99.98%	100.10%	99.76%	100.05%
Interest Burden Percent	144.11%	-67.38%	116.31%	101.40%	103.24%	101.07%	113.55%	107.08%	108.97%	115.74%	131.14%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-187.11%	-2,471.62%	-162.60%	-156.65%	-321.96%	0.00%	-446.90%	-294.47%	-469.06%	-482.38%	-350.64%
ROIC Less NNEP Spread (ROIC-NNEP)	-324.68%	-2,805.93%	199.65%	-178.44%	-412.44%	0.00%	-339.66%	-352.94%	-822.12%	-560.01%	-387.80%
Return on Net Nonoperating Assets (RNNOA)	-390.83%	2,054.67%	45.97%	-338.44%	-1,350.00%	0.00%	-449.38%	-353.37%	-960.62%	-3,493.19%	-361.16%
Return on Equity (ROE)	-577.93%	-416.95%	-116.63%	-495.09%	-1,671.95%	-6,150.41%	-896.28%	-647.84%	-1,429.68%	-3,975.56%	-711.80%
Cash Return on Invested Capital (CROIC)	-374.11%	0.00%	-424.81%	-469.97%	-737.39%	-3,344.54%	-568.73%	-242.88%	-360.01%	-542.45%	-325.02%
Operating Return on Assets (OROA)	-96.66%	5.89%	-13.29%	-57.50%	-81.56%	-146.76%	-26.08%	-95.25%	-199.33%	-115.16%	-91.18%
Return on Assets (ROA)	-139.28%	10.75%	-15.31%	-48.75%	-87.00%	-148.32%	-29.55%	-101.97%	-217.43%	-132.97%	-119.64%
Return on Common Equity (ROCE)	950.99%	-64.55%	-10.97%	-287.86%	-126.96%	-6,150.41%	-896.28%	-647.84%	-1,429.68%	-3,975.56%	-711.80%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-671.00%	-431.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.32	-12	-5.99	-6.54	-7.85	-10	-5.48	-5.65	-5.02	-6.18	-4.26
NOPAT Margin	-766.28%	-4,241.51%	-523.44%	-317.96%	-265.78%	-323.16%	-218.22%	-240.38%	-266.50%	-329.77%	-439.56%
Net Nonoperating Expense Percent (NNEP)	137.58%	334.31%	-362.25%	21.79%	90.48%	-423.47%	-107.23%	58.47%	353.06%	77.63%	37.15%
Return On Investment Capital (ROIC_SIMPLE)	1,266.41%	-114.97%	-71.14%	-50.75%	-87.69%	-691.49%	-94.62%	-102.99%	-85.75%	-56.34%	-27.87%
Cost of Revenue to Revenue	99.77%	115.44%	83.14%	64.48%	43.40%	46.77%	59.38%	42.60%	49.47%	69.01%	81.03%
SG&A Expenses to Revenue	671.13%	5,495.79%	642.62%	423.23%	342.04%	495.61%	323.74%	349.28%	399.20%	478.51%	602.78%
R&D to Revenue	423.79%	548.07%	122.01%	66.52%	49.12%	19.28%	28.63%	20.68%	32.04%	23.57%	44.12%
Operating Expenses to Revenue	1,083.37%	6,043.86%	764.63%	489.75%	436.29%	514.89%	352.37%	400.81%	431.24%	502.08%	646.91%
Earnings before Interest and Taxes (EBIT)	-4.92	0.51	-1.52	-9.06	-11	-20	-2.02	-7.73	-14	-8.77	-4.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.60	0.86	-1.01	-8.45	-10	-19	-1.49	-7.26	-14	-8.31	-4.04
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	21.47	14.13	5.87	5.65	0.00	105.03	87.85	0.00	3.61	3.72
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	81.70	112.93	30.21	12.78	4.85	7.00	3.36	3.40	3.70	1.96	4.64
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	55.05	0.00	11.04	4.28	3.96	64.53	8.10	8.04	15.36	2.14	2.89
Enterprise Value to Revenue (EV/Rev)	87.66	102.51	30.86	13.84	5.34	7.45	3.80	3.84	3.99	2.66	5.19
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-1.67	1.41	1.03	0.51	0.62	-1.49	15.93	11.91	-18.41	1.35	0.73
Long-Term Debt to Equity	0.00	0.27	0.27	0.13	0.23	-0.58	4.10	4.90	-3.27	0.42	0.12
Financial Leverage	1.20	-0.73	0.23	1.90	3.27	-3.42	1.32	1.00	1.17	6.24	0.93
Leverage Ratio	6.32	4.76	3.82	10.92	23.24	59.33	14.69	8.46	14.67	42.99	7.77
Compound Leverage Factor	9.11	-3.21	4.44	11.08	23.99	59.96	16.68	9.06	15.99	49.76	10.19
Debt to Total Capital	249.21%	58.47%	50.71%	33.79%	38.23%	305.20%	94.09%	92.25%	105.74%	57.48%	42.17%
Short-Term Debt to Total Capital	249.21%	47.10%	37.54%	24.96%	23.91%	185.42%	69.87%	54.29%	86.96%	39.60%	35.49%
Long-Term Debt to Total Capital	0.00%	11.38%	13.16%	8.83%	14.32%	119.78%	24.23%	37.96%	18.79%	17.88%	6.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	112.86%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-262.07%	41.53%	49.29%	66.21%	61.77%	-205.20%	5.91%	7.75%	-5.74%	42.52%	57.83%
Debt to EBITDA	-0.15	-0.24	-0.30	-0.33	-0.18	-0.12	-0.14	-0.13	-0.15	-0.20	-0.19
Net Debt to EBITDA	-0.14	0.34	-0.09	-0.31	-0.17	-0.11	-0.12	-0.13	-0.07	-0.19	-0.12
Long-Term Debt to EBITDA	0.00	-0.05	-0.08	-0.09	-0.07	-0.05	-0.04	-0.05	-0.03	-0.06	-0.03
Debt to NOPAT	-0.20	-0.20	-0.15	-0.16	-0.11	-0.15	-0.18	-0.17	-0.23	-0.28	-0.31
Net Debt to NOPAT	-0.20	0.28	-0.05	-0.15	-0.10	-0.13	-0.16	-0.17	-0.11	-0.27	-0.18
Long-Term Debt to NOPAT	0.00	-0.04	-0.04	-0.04	-0.04	-0.06	-0.05	-0.07	-0.04	-0.09	-0.05
Altman Z-Score	-5.56	-1.38	-3.31	-3.49	-4.57	-5.98	-5.05	-6.03	-6.79	-7.96	-6.79
Noncontrolling Interest Sharing Ratio	264.55%	84.52%	90.60%	41.86%	92.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.04	0.74	0.25	0.16	0.20	0.13	0.13	0.14	0.24	0.11	0.23
Quick Ratio	0.01	0.70	0.19	0.07	0.12	0.08	0.08	0.06	0.17	0.05	0.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2.81	-0.68	-4.35	-16	-15	-16	-5.06	1.79	1.10	-16	-12
Operating Cash Flow to CapEx	0.00%	-3,269.09%	-809.30%	0.00%	0.00%	0.00%	0.00%	0.00%	-17,357.69%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	1.30	-0.79	-17.53	-126.00	-41.68	-73.93	-18.46	3.28	0.85	-11.46	-8.63
Operating Cash Flow to Interest Expense	-0.72	-4.20	-32.63	-24.24	-10.35	-4.41	-2.14	-7.47	-3.49	-3.45	-3.06
Operating Cash Flow Less CapEx to Interest Expense	-0.44	-4.32	-36.67	-23.87	-7.43	-4.41	-2.14	-7.47	-3.51	-3.45	-3.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.09	0.03	0.10	0.13	0.22	0.24	0.32	0.29	0.26	0.25	0.20
Accounts Receivable Turnover	0.00	0.00	0.00	5.12	4.50	8.56	9.99	7.42	4.69	5.96	5.89
Inventory Turnover	0.00	0.00	0.00	2.73	3.81	6.06	7.61	3.34	3.10	3.91	3.35
Fixed Asset Turnover	0.00	0.00	0.00	2.08	4.24	6.37	9.33	9.54	13.17	12.78	18.15
Accounts Payable Turnover	0.00	0.00	0.00	0.31	0.39	0.60	0.58	0.50	0.50	0.50	0.43
Days Sales Outstanding (DSO)	0.00	0.00	0.00	71.26	81.19	42.62	36.53	49.18	77.83	61.29	61.97
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	133.57	95.89	60.22	47.96	109.44	117.57	93.28	109.04
Days Payable Outstanding (DPO)	0.00	0.00	0.00	1,174.66	930.23	613.18	625.08	736.88	737.22	730.77	848.82
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	-969.83	-753.15	-510.34	-540.59	-578.25	-541.82	-576.21	-677.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1.95	-4.28	5.43	13	8.69	1.08	5.01	5.25	2.58	11	13
Invested Capital Turnover	0.24	0.58	0.31	0.49	1.21	-5.82	2.05	1.23	1.76	1.46	0.80
Increase / (Decrease) in Invested Capital	-6.13	-11	-1.65	9.46	6.74	5.36	-0.42	-7.44	-6.11	9.63	7.72
Enterprise Value (EV)	107	85	60	54	34	69	41	42	40	23	37
Market Capitalization	100	94	59	50	31	65	36	37	37	17	33
Book Value per Share	($1.92)	$1.57	$0.16	$0.28	$0.19	($0.08)	$0.01	$0.01	($0.01)	$0.09	$0.09
Tangible Book Value per Share	($5.70)	($6.46)	($0.69)	($0.83)	($0.91)	($0.95)	($0.81)	($0.55)	($0.55)	($0.45)	($0.19)
Total Capital	2.04	11	8.43	13	8.95	1.48	5.79	5.49	5.85	11	15
Total Debt	5.08	6.15	4.27	4.36	3.42	4.52	5.45	5.06	6.19	6.31	6.45
Total Long-Term Debt	0.00	1.20	1.11	1.14	1.28	1.77	1.40	2.08	1.10	1.96	1.02
Net Debt	4.99	-8.65	1.28	4.15	3.16	4.12	4.67	4.82	2.91	6.04	3.89
Capital Expenditures (CapEx)	-0.61	0.11	1.00	-0.05	-1.02	0.00	0.00	0.00	0.03	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-15	-15	-13	-18	-19	-22	-24	-20	-19	-18	-16
Debt-free Net Working Capital (DFNWC)	-15	-0.62	-10	-18	-19	-22	-23	-20	-16	-18	-13
Net Working Capital (NWC)	-20	-5.58	-14	-21	-21	-25	-28	-23	-21	-22	-19
Net Nonoperating Expense (NNE)	3.77	-13	-4.24	1.14	3.69	9.60	-3.19	2.62	11	3.94	1.59
Net Nonoperating Obligations (NNO)	4.99	-8.65	1.28	4.15	3.16	4.12	4.67	4.82	2.91	6.04	3.89
Total Depreciation and Amortization (D&A)	0.32	0.35	0.52	0.61	0.54	0.59	0.53	0.47	0.47	0.46	0.42
Debt-free, Cash-free Net Working Capital to Revenue	-1,193.06%	-1,857.71%	-690.12%	-469.73%	-294.33%	-238.84%	-226.81%	-184.65%	-194.29%	-212.25%	-221.49%
Debt-free Net Working Capital to Revenue	-1,185.78%	-75.06%	-536.08%	-464.50%	-290.20%	-234.50%	-219.50%	-182.47%	-161.27%	-209.14%	-185.28%
Net Working Capital to Revenue	-1,600.74%	-671.69%	-698.87%	-546.57%	-323.44%	-263.94%	-257.34%	-209.58%	-212.58%	-259.57%	-261.98%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.36)	$0.04	($0.09)	($0.25)	($0.43)	($0.52)	($0.60)	($0.17)	($0.26)	($0.16)	($0.59)
Adjusted Weighted Average Basic Shares Outstanding	14.61M	18.62M	28.05M	30.55M	28.42M	38.43M	4.02M	48.79M	45.47M	63.06M	9.84M
Adjusted Diluted Earnings per Share	($0.36)	$0.04	($0.21)	($0.25)	($0.33)	($0.52)	($0.60)	($0.17)	($0.26)	($0.16)	($0.59)
Adjusted Weighted Average Diluted Shares Outstanding	14.61M	23.32M	29.20M	30.55M	29.48M	38.43M	4.02M	48.79M	45.47M	63.06M	9.84M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	25.81M	27.19M	30.59M	35.81M	36.99M	5.33M	54.73M	66.31M	103.08M	13.44M
Normalized Net Operating Profit after Tax (NOPAT)	-3.32	-12	-5.99	-6.54	-7.85	-10	-5.48	-5.14	-5.02	-6.18	-4.26
Normalized NOPAT Margin	-766.28%	-4,241.51%	-523.44%	-317.96%	-265.78%	-323.16%	-218.22%	-218.79%	-266.50%	-329.77%	-439.56%
Pre Tax Income Margin	-1,636.49%	-121.05%	-154.50%	-446.26%	-377.96%	-626.10%	-91.44%	-352.09%	-834.91%	-541.28%	-603.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.27	0.60	-6.13	-71.32	-30.90	-93.03	-7.38	-14.13	-11.15	-6.35	-3.21
NOPAT to Interest Expense	-1.53	-14.11	-24.17	-51.52	-22.43	-48.54	-20.00	-10.33	-3.88	-4.48	-3.07
EBIT Less CapEx to Interest Expense	-1.99	0.47	-10.17	-70.95	-27.99	-93.03	-7.38	-14.13	-11.17	-6.35	-3.21
NOPAT Less CapEx to Interest Expense	-1.25	-14.23	-28.20	-51.16	-19.52	-48.54	-20.00	-10.33	-3.90	-4.48	-3.07
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-2.35%	-23.33%	-41.77%	-48.96%	-34.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Mobix Labs Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Mobix Labs' financial year ends in September. Their financial year 2025 ended on September 30, 2025.

Mobix Labs' net income appears to be on an upward trend, with a most recent value of -$46.13 million in 2025, rising from -$776.13 thousand in 2022. The previous period was -$20.03 million in 2024. See Mobix Labs' forecast for analyst expectations on what's next for the company.

Mobix Labs' total operating income in 2025 was -$37.69 million, based on the following breakdown:

Total Gross Profit: $5.01 million
Total Operating Expenses: $42.70 million

Over the last 3 years, Mobix Labs' total revenue changed from $0.00 in 2022 to $9.91 million in 2025, a change of 991,200,000.0%.

Mobix Labs' total liabilities were at $37.45 million at the end of 2025, a 11.6% increase from 2024, and a 2,056.9% increase since 2021.

In the past 4 years, Mobix Labs' cash and equivalents has ranged from $89 thousand in 2023 to $3.27 million in 2025, and is currently $3.27 million as of their latest financial filing in 2025.

Over the last 3 years, Mobix Labs' book value per share changed from -0.73 in 2022 to -0.01 in 2025, a change of -99.2%.

Related Companies

Financial statements for NASDAQ:MOBX last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mobix Labs (MOBX) Financials

Financials Breakdown Chart

Mobix Labs Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mobix Labs (MOBX) Financials

Annual Income Statements for Mobix Labs

Quarterly Income Statements for Mobix Labs

Annual Cash Flow Statements for Mobix Labs

Quarterly Cash Flow Statements for Mobix Labs

Annual Balance Sheets for Mobix Labs

Quarterly Balance Sheets for Mobix Labs

Annual Metrics And Ratios for Mobix Labs

Quarterly Metrics And Ratios for Mobix Labs

Financials Breakdown Chart

Mobix Labs Financials - Frequently Asked Questions

When does Mobix Labs' fiscal year end?

How has Mobix Labs' net income changed over the last 3 years?

What is Mobix Labs' operating income?

How has Mobix Labs' revenue changed over the last 3 years?

How much debt does Mobix Labs have?

How much cash does Mobix Labs have?

How has Mobix Labs' book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools